The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): A major ATP-binding residue

Diabetic Medicine

Volumn 27, Issue 2, 2010, Pages 225-229

  Shimomura, K ^a   De Nanclares, G P ^b   Foutinou, C ^a   Caimari, M ^c   Castano L ^b   Ashcroft, F M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Neonatal diabetes; Sulphonylurea

Indexed keywords

ADENOSINE TRIPHOSPHATE MAGNESIUM; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; TOLBUTAMIDE; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; INWARDLY RECTIFYING POTASSIUM CHANNEL;

ANIMAL CELL; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CASE REPORT; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DIURESIS; DRUG DOSE INCREASE; FEMALE; GENE MUTATION; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HUMAN; HYPERGLYCEMIA; HYPOTENSION; HYPOTHERMIA; INSULIN TREATMENT; INTUBATION; KETOACIDOSIS; NONHUMAN; NOSE FEEDING; NUCLEOTIDE SEQUENCE; OOCYTE; PRESCHOOL CHILD; REHYDRATION; RESPIRATORY DISTRESS; WILD TYPE; XENOPUS; DIABETIC KETOACIDOSIS; DNA SEQUENCE; GENETICS; METABOLISM; MUTATION; NEWBORN; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ATP-BINDING CASSETTE TRANSPORTERS; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SEQUENCE ANALYSIS, DNA;

EID: 76249101558     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02901.x     Document Type: Article

References (28)

1. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Eng J Med 2004 350 : 1838 1849.
2. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006 49 : 1190 1197.
3. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights and new therapy. Diabetes 2005 54 : 2503 2513.
4. Shimomura K, Girard CA, Proks P, Nazam J, Lippiat JD, Cerutti F et al. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes 2006 55 : 1705 1712.
5. Masia R, Koster JC, Tumini S, Chiarelli F, Colombo C, Nichols CG et al. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes 2007 56 : 328 336.
6. Proks P, Girard C, Haider S, Gloyn AL, Hattersley AT, Sansom MSP et al. A novel gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 2005 6 : 470 475.
7. Proks P, Antcliff JF, Lippiat J, Gloyn A, Hattersely A, Ashcroft FM. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 2004 101 : 17539 17544.
8. Koster JC, Cadario F, Peruzzi C, Colombo C, Nichols CG, Barbetti F. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor disfunction in adulthood that is improved with sulfonylurea therapy. J Clin Endocrinol Metab 2007 93 : 1054 1061.
9. Shimomura K, Hörster F, de Wet H, Flanagan SE, Ellard S, Hattersley AT et al. A novel mutation causing DEND syndrome - a treatable channelopathy of pancreas and brain. Neurology 2007 6 : 1342 1349.
10. Proks P, Girard C, Ashcroft FM. Enhanced activation by MgATP contributes significantly to the functional effects of KCNJ11 mutations causing neonatal diabetes. Hum Mol Genet 2005 14 : 2717 2726.
11. Pearson ER, Flechtner I, Njolstad PR, Neonatal Diabetes International Collaborative Group, Malecki MT, Flanagan S et al. The successful transfer of insulin treated patient with diabetes due to kir6.2 (KCNJ11) mutations to sulphonylurea tablets. N Engl J Med 2006 355 : 467 477.
12. Nichols CG. KATP channels as molecular sensors of cellular mechanism. Nature 2006 440 : 470 476.
13. Ashcroft FM. ATP-sensitive K+ channel and disease: from molecule to malady. Am J Physiol Endocrinol Metab 2007 293 : E880 E889.
14. Ashcroft FM, Harrison DE, Ashcroft SJH. Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature 1984 312 : 446 448.
15. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000 49 : 1751 1760.
16. Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG. Targeted overactivity of beta cell KATP channels induces profound neonatal diabetes. Cell 2000 100 : 645 654.
17. Remedi MS, Kurata HT, Scott A, Wunderlich FT, Rother E, Kleinridders A et al. Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus. Cell Metab 2009 9 : 140 151.
18. Girard CA, Wunderlich FT, Shimomura K, Collins S, Kaizik S, Proks P et al. A mouse model of neonatal diabetes caused by the KATP channel mutation Kir6.2-V59M. J Clin Invest 2009 119 : 80 90.
19. Gribble FM, Reinmann F. Sulphonylurea action revisited: the post-cloning era. Diabetologia 2003 46 : 875 891.
20. Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM. Truncation of Kir6.2 produces ATP sensitive K+ channels in absence of the sulphonylurea receptor. Nature 1997 387 : 179 181.
21. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP IV., Gonzalez G et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 1996 272 : 1785 1787.
22. Gribble FM, Tucker SJ, Ashcroft FM. The essential role of the Walker A motifs of SUR1 in KATP channel activation by MgADP and diazoxide. EMBO J 1997 16 : 1145 1152.
23. Antcliff JF, Haider S, Proks P, Sansom MSP, Ashcroft FM. Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. EMBO J 2005 24 : 229 239.
24. Trapp S, Haider S, Jones P, Sansom MS, Ashcroft FM. Identification of residues contributing to ATP binding site of Kir6.2. EMBO J 2003 22 : 2903 2912.
25. Haider S, Khalid S, Tucker SJ, Ashcroft FM, Sansom MS. Molecular dynamics simulations of inwardly rectifying (Kir) potassium channels: a comparative study. Biochemistry 2007 46 : 3643 3652.
26. Tanabe K, Tucker SJ, Matsuo M, Proks P, Ashcroft FM, Seino S et al. Direct photoaffinity labeling of the Kir6.2 subunit of the ATP-sensitive K + channel by 8-azide-ATP. J Biol Chem 1999 274 : 3931 3933.
27. Ribalet B, John SA, Weiss JN. Molecular basis for Kir6.2 channel inhibition by adenosine nucleotides. Biophys J 2003 84 : 266 276.
28. Koster JC, Sha Q, Shyng SL, Nichols CG. ATP inhibition of KATP channels: control of nucleotide sensitivity by the N-terminal domain of the Kir6.2 subunit. J Physiol 1999 515 : 19 30.